logo

For the Inventor, By the Inventor

Wilmington, DE, United States of America

Dcb-USA LLC

USPTO Granted Patents = 16

% Expired Patents = 6.3



Forward Citations = 16

Loading Chart...
Loading Chart...

52 inventors (with patents filed for the assignee):

goldMedal Jiann-Shiun Lai (5 out of 7 patents)

silverMedal Chao-Yang Huang (3 out of 8 patents)

bronzeMedal Woan-Eng Chan (3 out of 3 patents)

4.  Kuen-Feng Chen (2 out of 6 patents)

5.  Chung-Wai Shiau (2 out of 9 patents)

6.  Ta-Tung Yuan (2 out of 8 patents)

7.  Ying-Yung Lok (2 out of 5 patents)

8.  Yu-Shen Hsu (2 out of 5 patents)

9.  Jang-Yang Chang (2 out of 13 patents)

10.  Biing-Jiun Uang (2 out of 9 patents)

11.  Tian-Lu Cheng (1 out of 15 patents)

12.  Jing-Ping Liou (1 out of 23 patents)

13.  Tur-Fu Huang (1 out of 6 patents)

14.  Yu-Ju Kuo (1 out of 1 patent)

15.  Woei-Jer Chuang (1 out of 8 patents)


16 patents:

1. 11202854 - Disintegrin variants and uses thereof (2021-12-21),
2. 11142567 - Anti-dengue virus antibody, pharmaceutical composition comprising the same, and uses thereof (2021-10-12),
3. 10633453 - Antibody locker for the inactivation of protein drug (2020-04-28),
4. 9527922 - Humanized alpha-enolase specific antibodies and methods of uses in cancer therapy (2016-12-27),
5. 9428575 - Anti-granulysin antibodies and methods of use thereof (2016-08-30),
6. 9315491 - Pyrimidine compounds as mTOR and PI3K inhibitors (2016-04-19),
7. 9216950 - Agonists of Src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same (2015-12-22),
8. 9090617 - Agonists of Src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same (2015-07-28),
9. 8961971 - Bispecific T-cell activator antibody (2015-02-24),
10. 8895497 - Cathepsin S inhibitors (2014-11-25),
11. 8633252 - Use of pterosin compounds for treating diabetes and obesity (2014-01-21),
12. 8431118 - Anti-herpes simplex virus antibodies and methods of use thereof (2013-04-30),
13. 8252906 - Anti-herpes simplex virus antibodies and methods of use thereof (2012-08-28),
14. 8241608 - [object Object] (2012-08-14),
15. 8119683 - Aryl substituted sulfonamide compounds and their use as anticancer agents (2012-02-21),
Company Overview
Dcb-USA LLC is a technology-focused company based in Wilmington, Delaware, specializing in advanced solutions for various industries. The organization is dedicated to the development and manufacturing of innovative products that enhance operational efficiency and performance. With a strong emphasis on research and development, Dcb-USA LLC operates in domains such as electronics and software, aiming to deliver cutting-edge technologies that meet the evolving needs of its clients across diverse markets.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

16 Patents

#246 in Wilmington, DE

#312 in Delaware

#19,935 in US

#37,868 in the World

Wilmington, DE (US)
Wilmington, DE, United States of America

Dcb-USA LLC

Forward Citations = 16

52 inventors:

goldMedal Jiann-Shiun Lai (5 out of 7 patents)

silverMedal Chao-Yang Huang (3 out of 8 patents)

bronzeMedal Woan-Eng Chan (3 out of 3 patents)

4.  Kuen-Feng Chen (2 out of 6 patents)

5.  Chung-Wai Shiau (2 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dcb-USA LLC. Retrieved from https://idiyas.com/company/dcb-usa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…